Skip to main content

Eli Lilly and Company Neuroscience revenue

  • LLY · NYSE
  • Pharmaceuticals
  • S&P 500
$1443.50+1.14%Close 13 Nov 2026 · Market value $1.36T

Neuroscience revenue at Eli Lilly and Company came to $384.0M for the quarter to 30 Sep 2026, up 60.0% from a year earlier.

As Eli Lilly and Company reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 29 Oct 2026.

By quarter

$183.2MDec 2023$163.2MMar 2024$191.9MJun 2024$201.3MSep 2024$223.5MDec 2024$189.0MMar 2025$248.0MJun 2025$240.0MSep 2025$320.0MDec 2025$293.0MMar 2026$325.0MJun 2026$384.0MSep 2026
Eli Lilly and Company Neuroscience revenue, every reported period
Period endingNeuroscience revenueChange on a yearFiled
30 Sep 2026$384.0Mup 60.0%29 Oct 2026
30 Jun 2026$325.0Mup 31.0%5 Aug 2026
31 Mar 2026$293.0Mup 55.0%30 Apr 2026
31 Dec 2025$320.0Mup 43.2%12 Feb 2026
30 Sep 2025$240.0Mup 19.2%30 Oct 2025
30 Jun 2025$248.0Mup 29.2%7 Aug 2025
31 Mar 2025$189.0Mup 15.8%1 May 2025
31 Dec 2024$223.5Mup 22.0%19 Feb 2025
30 Sep 2024$201.3Mdown 2.9%30 Oct 2024
30 Jun 2024$191.9Mup 19.3%8 Aug 2024
31 Mar 2024$163.2Mup 12.9%30 Apr 2024
31 Dec 2023$183.2Mup 8.8%21 Feb 2024
30 Sep 2023$207.4Mup 42.2%2 Nov 2023
30 Jun 2023$160.9Mup 11.1%8 Aug 2023
31 Mar 2023$144.5Mdown 5.8%27 Apr 2023
31 Dec 2022$168.4Mup 4.1%22 Feb 2023
30 Sep 2022$145.8Mup 0.8%1 Nov 2022
30 Jun 2022$144.8Mdown 13.1%4 Aug 2022
31 Mar 2022$153.4Mup 8.3%29 Apr 2022
31 Dec 2021$161.7Mup 21.9%23 Feb 2022
30 Sep 2021$144.6Mup 3.0%27 Oct 2021
30 Jun 2021$166.7Mup 60.3%3 Aug 2021
31 Mar 2021$141.7Mup 28.5%30 Apr 2021
31 Dec 2020$132.6Mup 24.7%17 Feb 2021
30 Sep 2020$140.4Mup 48.4%28 Oct 2020
30 Jun 2020$104.0Mdown 0.4%31 Jul 2020
31 Mar 2020$110.3Mup 115.9%1 May 2020
31 Dec 2019$106.3Mup 66.4%19 Feb 2020
30 Sep 2019$94.6Mup 69.5%25 Oct 2019
30 Jun 2019$104.4Mup 59.1%2 Aug 2019
31 Mar 2019$51.1Mdown 44.0%2 May 2019
31 Dec 2018$63.9M—19 Feb 2019
30 Sep 2018$55.8M—6 Nov 2018
30 Jun 2018$65.6M—25 Jul 2018
31 Mar 2018$91.2M—27 Apr 2018

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Eli Lilly and Company: Cardiometabolic Health revenue · Zepbound revenue · Mounjaro revenue · Oncology revenue · Verzenio revenue · Immunology revenue · Jardiance revenue · Trulicity revenue · Taltz revenue · United States revenue · Outside U.S. revenue · Europe revenue · Rest of world revenue · China revenue · Japan revenue · financial statements

Every KPI and segment of LLY, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.